JANELLE BROWN TAFT: Open Payments
NPI 1326289034 · WILSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 27 payments from 13 companies in 2025. Trend: 2023 $558 · 2024 $461 · 2025 $729
Food & beverage: $729
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $150 |
| Galderma Laboratories, L.P. | 1 | $125 |
| Novo Nordisk Inc | 5 | $95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71 |
| Merck Sharp & Dohme LLC | 3 | $63 |
| Amgen Inc. | 4 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| SANOFI PASTEUR INC. | 1 | $26 |
| Lilly USA, LLC | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: FARXIGA, JARDIANCE, OTEZLA, ROTATEQ, Rybelsus, TRINTELLIX, Ozempic, BREZTRI.
Industry payments across NC — which companies pay providers there.
